J&J solidifies oncology leadership in multiple myeloma as Talvey and Darzalex Faspro combo triumphs in early-stage trial At a plenary... Read more
Tag: #Global Trends
Draft Amended Food Safety Law: Proposals mandate identity verification for social media vendors and criminalize banned substance usage
The Ministry of Justice has officially published the evaluation dossier for the revised draft of the Food Safety Law. Within... Read more
France recalls Novalac formula batch: Manufacturer isolates root cause of color and odor anomalies
The French government has officially confirmed the voluntary preventive recall of an infant formula batch executed by Novalac following a... Read more
FDA clears expanded approval for Sanofi’s type 1 diabetes drug Tzield in Stage 3 pediatric cohorts
The U.S. Food and Drug Administration (FDA) has formally approved the expanded clinical utilization of Sanofi’s injectable metabolic therapy, Tzield.... Read more
Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization, has formally applauded the decision issued by... Read more
Amgen taps Duke Clinical Research Institute to independently review Tavneos data amid FDA withdrawal proposal
U.S. biotechnology giant Amgen has officially retained an independent third-party research institution to conduct an un-biased evaluation of the clinical... Read more
Takeda’s $4 billion TYK2 inhibitor zasocitinib outperforms Bristol Myers’ Sotyktu in head-to-head psoriasis trial
Japanese drugmaker Takeda has officially announced positive top-line readouts from a head-to-head clinical trial, demonstrating that its investigational autoimmune candidate,... Read more
J&J eyes rare disease expansion for future blockbuster Imaavy following successful Phase 2/3 anemia trial
Johnson & Johnson (J&J) has unveiled positive data from its pivotal Phase 2/3 clinical trial, designated as the Energy study,... Read more
Novo Nordisk reports internal IT data breach, advising clinical trial patients to ‘remain vigilant’
Danish pharmaceutical giant Novo Nordisk has officially issued a security incident notice confirming a targeted cyberattack that compromised specific components... Read more









